This company has been acquired
Prometheus Biosciences Balance Sheet Health
Financial Health criteria checks 6/6
Prometheus Biosciences has a total shareholder equity of $697.6M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $758.4M and $60.8M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$713.67m |
| Equity | US$697.62m |
| Total liabilities | US$60.80m |
| Total assets | US$758.41m |
Recent financial health updates
We Think Prometheus Biosciences (NASDAQ:RXDX) Can Afford To Drive Business Growth
May 17
Here's Why We're Not Too Worried About Prometheus Biosciences' (NASDAQ:RXDX) Cash Burn Situation
Dec 03We Think Prometheus Biosciences (NASDAQ:RXDX) Needs To Drive Business Growth Carefully
Aug 19We're Hopeful That Prometheus Biosciences (NASDAQ:RXDX) Will Use Its Cash Wisely
May 04Prometheus Biosciences (NASDAQ:RXDX) Is In A Good Position To Deliver On Growth Plans
Nov 16Recent updates
We Think Prometheus Biosciences (NASDAQ:RXDX) Can Afford To Drive Business Growth
May 17Here's Why We're Not Too Worried About Prometheus Biosciences' (NASDAQ:RXDX) Cash Burn Situation
Dec 03We Think Prometheus Biosciences (NASDAQ:RXDX) Needs To Drive Business Growth Carefully
Aug 19Prometheus Biosciences GAAP EPS of -$0.86 beats by $0.06, revenue of $1.26M beats by $0.8M
Aug 11We're Hopeful That Prometheus Biosciences (NASDAQ:RXDX) Will Use Its Cash Wisely
May 04Prometheus: Biotech To Watch With A Monoclonal Antibody For Immune-Mediated Diseases
Dec 08Prometheus Biosciences (NASDAQ:RXDX) Is In A Good Position To Deliver On Growth Plans
Nov 16Prometheus Biosciences: Precision Medicine For IBD
Sep 22Financial Position Analysis
Short Term Liabilities: RXDX's short term assets ($726.4M) exceed its short term liabilities ($19.3M).
Long Term Liabilities: RXDX's short term assets ($726.4M) exceed its long term liabilities ($41.5M).
Debt to Equity History and Analysis
Debt Level: RXDX is debt free.
Reducing Debt: RXDX had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: RXDX has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: RXDX has sufficient cash runway for more than 3 years if free cash flow continues to reduce at historical rates of 48.2% each year